Senior Correspondent, London
Ben's Feed
Apr 7, 2014
Apr 6, 2014

Drugmaker GSK investigates alleged bribery in Iraq

LONDON (Reuters) – Drugmaker GlaxoSmithKline, already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the British company said on Sunday.

The latest controversy centers on claims that the company hired government-employed physicians and pharmacists in Iraq as paid sales representatives to improperly boost use of its products.

Apr 4, 2014
Apr 4, 2014
Apr 2, 2014
Apr 2, 2014
Apr 2, 2014
Apr 2, 2014
Apr 2, 2014

GlaxoSmithKline throws in towel on lung cancer vaccine trial

LONDON (Reuters) – GlaxoSmithKline Plc (GSK) has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to find a sub-group of patients who might benefit.

The decision comes less than two weeks after GSK said the MAGE-A3 therapeutic vaccine did not help patients with non-small cell lung cancer in the Phase III study overall, but it was still looking for improvements among patients with a particular genetic profile.

Apr 1, 2014
    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."
    • More from Ben

    • Follow Ben